El interés en corto de Chemomab Therapeutics da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Chemomab Therapeutics. Los datos de interés en corto se actualizan cada dos semanas.

Chemomab Therapeutics (NASDAQ:CMMB) Bolsa, Informe de interés en corto

Chemomab Therapeutics

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.

Chemomab Therapeutics Ltd. - American Depositary Shares

Chemomab Therapeutics Ltd

On Tuesday, Johnson &amp; Johnson (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jnj#NYSE">JNJ</a>) posted better-than-expected third quarter sales and adjusted profit. Fueled by strong results, Johnson &amp; Johnson raised its full year profit and sales guidance. Also on Wednesday, the&nbsp;struggling pharmacy chain operator, Walgreens Boots Alliance Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wba#NASDAQ">WBA</a>) announced it will be shutting down 1,200 of its stores.&nbsp;Under the new leadership of Tim Wentworth, WBA has embarked on a turnaround journey amid a challenging climate shaped by sluggish consumer spending and low drug reimbursement rates.
<h3>Third Quarter Highlights</h3>
For the quarter ended in September, the pharmaceutical and medical device company&nbsp;posted sales&nbsp;of $22.47 billion,&nbsp;implying a YoY growth of 5.2%.&nbsp;
Medical devices unit reported sales grew 5.8% to $7.9 billion, but MedTech had faced &ldquo;headwinds&rdquo; in the form of economic slowdowns in China and Japan, as well as a physician&rsquo;s strike in Korea.
Across the globe, J&amp;J&#39;s cancer drugs rose nearly 19%,&nbsp;led by more than $3 billion for multiple myeloma treatment Darzalexwhose sales grew 20.7% YoY due to regulatory approval for additional uses.&nbsp;CFO&nbsp;Joe Wolk&nbsp;said that the continued adoption of the subcutaneous version of Darzalex has been shown to significantly reduce treatment time.&nbsp;Cancer cell therapy, Carvykti, brought in sales of $286 million.
On the other hand, its&nbsp;blockbuster psoriasis drug Stelara postes a revenue drop of 6.6% as sales amounted to $2.68 billion, with sales expected to fall further next year with as many as&nbsp;six biosimilar competitors in the U.S.&nbsp;
Due to one-time expenses including acquisitions and legal costs, net income tanked 38% to $2.69 billion. But although adjusted earnings dropped 9% YoY to $2.42 per share, they still topped LSEG&rsquo;s consensus estimate of&nbsp;$2.21&nbsp;per share.&nbsp;
<h3>An Outlook Boost</h3>
The New Jersey-based healthcare conglomerate&nbsp;lifted its full year outlook. While Johnson and Johnson previously expected to post full year sales between&nbsp;$89.2 billion and $89.6 billion, it now guided for a range between $89.4 billion and $89.8 billion. Including one-time charges related to mergers and acquisitions, Johnson &amp; Johnson expects full year earnings to be between $9.86 and $9.96 per share, having tweaked its prior estimate due to&nbsp;improved performance outlook&nbsp;that was offset by a charge from its latest acquisition that closed last week, concerning the privately-held medical technology company V-Wave
Despite Stelara&#39;s loss of exclusivity, J&amp;J remains confident it can post 2025 pharmaceutical sales above its $57 billion target.
Although talc ligitation concerns remain as a cloud over its long-term picture, Johnson &amp; Johnson has atleast eased worries when it comes to its current business&nbsp;and&nbsp;financial performance.
DISCLAIMER: This content is for informational purposes only. It is not intended as investing advice.
This article is from an unpaid external contributor. It does not represent Benzinga&#39;s reporting and has not been edited for content or accuracy.

Biotech

Markets

General

Cancer Drugs Propel J&J Beyond Wall Street Estimates

Into The Cryptoverse founder Benjamin Cowen sees Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) near-term trend depending on the upcoming labour market report <a href="https://www.benzinga.com/topic/2024-election">and election results</a>.
What Happened: The analyst highlighted in a social media <a href="https://x.com/intocryptoverse/status/1846204889354965163">post</a> on Tuesday that while short-term predictions are challenging, market momentum may start to wane as we approach the release of the November labor market report and election results. 
He further added that the market would likely find its next real direction after these significant events.
Cowen pointed out that Bitcoin has often rallied up to the lower high structure during the middle-to-late part of a month, only to trade sideways until after labor market data has been released.
He suggested that the next direction for Bitcoin would likely depend on fresh labor market data, coming out on Nov.1.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/digital-assets"><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41336897/3-reasons-why-a-bitcoin-all-time-high-before-the-election-is-back-in-play">3 Reasons Why A Bitcoin All-Time High Before The Election Is Back In Play</a>
Why It Matters: Cowen&#8217;s predictions suggest that major economic and political events can have a direct impact on market trends. He highlighted the importance of the labor market report and election results.
These forecasts come in the wake of a $555.8 million in <a href="https://www.benzinga.com/money/best-spot-bitcoin-etfs">Bitcoin spot ETF</a> inflows on Monday. 
On Oct. 14, Cowen noted that Bitcoin is holding the bull market support band for the last few weeks. He had then <a href="https://x.com/intocryptoverse/status/1845820987641643410">predicted</a> if "late-October seasonality kicks in (which is usually bullish), the $67,000-$68,000 area could be next."
What&#8217;s Next: The influence of&nbsp;<a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a>&nbsp;is expected to be thoroughly explored at Benzinga&#8217;s upcoming&nbsp;<a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a>&nbsp;event on Nov. 19.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41331856/bitcoin-spot-etfs-saw-555-8m-net-inflows-on-monday-monster-day">Bitcoin Spot ETFs Saw $555.8M Net Inflows On &#8216;Monster&#8217; Monday</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

$BTC

Bitcoin's Next Big Move To Be Decided By Election Result And Labor Market Report, Says Benjamin Cowen

There&#39;s a saying that stocks don&#39;t move in one direction all the time. Palantir Technologies Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pltr#NYSE">PLTR</a>) is testing the logic behind that saying. PLTR stock is up a whopping 151% in 2024 nearly matching the 168% gain in NVIDIA Corp.&nbsp;
Furthermore, the stock is up 24% in the last month alone. This has brought Palantir&#39;s market cap close to $100 billion. For context, the company started out the year with a $37 billion market cap. &nbsp;
The recent stock price move corresponds to the company&#39;s inclusion in the S&amp;P 500. That was expected to raise the stock price as institutional money flowed in. However, many investors expected there to be an initial pullback.&nbsp;&nbsp;
However, that hasn&#39;t been the case. But with the stock above $43 a share, it&#39;s now moving into an area that is overbought by technical indicators. If you&#39;re a long-term investor, any talk of selling Palantir at this price is quickly dismissed. But at its current price, many traders are asking if now is a time to take some profit. Without giving specific investment advice, let&#39;s look at what you should know before making a decision. &nbsp;
<h2>Palantir is Objectively Overvalued&nbsp;</h2>
By any objective fundamental measure, PLTR stock is expensive. The price-to-earnings (P/E) ratio is 359.45, the price-to-sales (P/S) is 41.7, and the PEG is 4.6. &nbsp;
Even among technology stocks, metrics like those suggest that investors are pulling forward a lot of future earnings. However, bulls will argue that there&#39;s a difference between price and value. And stocks like Palantir and NVIDIA can be overvalued for a long time before they grow into their valuation. &nbsp;
<h2>Palantir is Different&nbsp;</h2>
But it may be expensive for a reason. A key reason is Palantir&#39;s ontology, which is how Palantir&#39;s software makes large language models (LLMs) useful. In layman&#39;s terms, Palantir&#39;s ontology allows businesses to get useful insight from their AI investments.&nbsp;
Without a useful ontology, AI has little value for companies. However, as Palantir continues to stack up contracts from both the government and commercial sides, it&#39;s clear that many people are seeing the value in Palantir&#39;s software. It&#39;s also important to note that Palantir&#39;s platform gives its customers the ability to leverage multiple LLMs so customers can experiment with the strengths of various models within the same platform. &nbsp;
<h2>Why You Shouldn&#39;t Sell PLTR Stock&nbsp;</h2>
Palantir skeptics will point out that there&#39;s been a large amount of insider selling in PLTR stock in the last 90 days. You can find a list of these on the Insider Trades page for Palantir stock on MarketBeat. However, in many of these cases, the trading was done as part of a Rule 10b5-1 trading plan. That means that these trades were planned for a long time without the insiders having any knowledge of what the stock price would be at the time they sold.
This should remind investors that there are many reasons to sell a stock. In the case of Palantir, many of these executives may receive a significant part of their compensation as stock. &nbsp;
<h2>A Possible Options Trade&nbsp;</h2>
If you&#39;re comfortable with options trading, an option could be to buy puts on PLTR with a longer-dated expiration date. That gives you the right, but not the obligation, to purchase shares if the stock falls to your strike price. If you do buy the shares, you&#39;ll be getting them at the new price which could help your average cost if you bought the shares recently. Otherwise, you can simply let the option(s) expire, and you&#39;ll have the same position in the stock.&nbsp;
<h2>One Size Doesn&#39;t Fit All&nbsp;</h2>
The challenge with a stock like Palantir is that your decision to buy or sell will depend on many factors. For example, if you purchased shares when they were at $30 a share, the decision to take some profit may be easier than if you bought shares when the stock was trading for around $8. &nbsp;
It&#39;s possible, but unlikely, that the stock will trade at that level again. Selling some of those shares gives you a larger profit, but you&#39;ll never get shares at that low price again. &nbsp;
Tough call. &nbsp;
Ultimately, investors should always remember that, like corporate insiders, retail investors have many reasons to sell a stock. Only you can answer how you would feel if PLTR stock dropped by 20% or more. &nbsp;
The article &quot;<a href="https://www.marketbeat.com/originals/at-43-is-it-time-to-take-profit-with-palantir/">At $43 is it Time to Take Profit with Palantir?</a>&quot; first appeared on MarketBeat.

Earnings

Financial Advisors

Large Cap

Price Target

Contracts

Insider Trades

Analyst Ratings

Tech

Personal Finance

Trading Ideas

PLTR

At $43 is it Time to Take Profit with Palantir?

Clipper Realty Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/clpr#NYSE">CLPR</a>) shares soared 9.9% in the last trading session to close at $6.65. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock&#39;s 12.7% gain over the past four weeks.
The increased investor optimism in the stock can be attributed to the favorable operating environment.
This company is expected to post quarterly funds from operations (FFO) of $0.12 per share in its upcoming report, which represents a year-over-year change of -20%. Revenues are expected to be $38 million, up 8.2% from the year-ago quarter.
FFO and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in FFO estimate revisions are strongly correlated with near-term stock price movements.
For Clipper Realty, the consensus FFP per share estimate for the quarter has been revised 33.3% higher over the last 30 days to the current level. And a positive trend in FFO estimate revision usually translates into price appreciation. So, make sure to keep an eye on CLPR going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #1 (Strong Buy).
Clipper Realty is part of the Zacks REIT and Equity Trust - Other industry. NNN REIT (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nnn#NYSE">NNN</a>), another stock in the same industry, closed the last trading session 1% higher at $47.95. NNN has returned -2.6% in the past month.
For NNN REIT, the consensus FFO per share estimate for the upcoming report has remained unchanged over the past month at $0.84. This represents a change of +2.4% from what the company reported a year ago. NNN REIT currently has a Zacks Rank of #3 (Hold).
<a href="https://www.zacks.com/stock/news/2350779/clipper-realty-clpr-soars-9-9-is-further-upside-left-in-the-stock?cid=CS-BENZ-FT-tale_of_the_tape|daily_price_change_5%-2350779">To read this article on Zacks.com click here.</a>

Mid Cap

REIT

Small Cap

Real Estate

CLPR

Clipper Realty Soars 9.9%: Is Further Upside Left in the Stock?

Macro Economic Events

Macro Notification

Market Summary

Economics

ASML

BABA

SPDR Dow Jones Industrial Average ETF Trust

NVDA

SCHW

Benzinga Market Summary: Indexes Fall Amid Weakness In Chip Stocks And Health Insurers, Schwab Surges After Client Assets Increase 27%, China Stocks Fall On Weak Exports And Continued Stimulus Uncertainty

Combining growth and income can be extremely valuable when investing in the stock market. While dividends can provide a stable and consistent stream of cash, the potential for growth can lead to capital appreciation. These three stocks have provided significant income to shareholders and are expected to keep doing so. Additionally, they show avenues for solid growth.
<h2>Frontline: Income the Size of an Oil Tanker</h2>
First up is Frontline PLC (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fro#NYSE">FRO</a>). Frontline operates a fleet of oil tankers. As of Jun. 30, 2024, the company operated 82 vessels. The company operates these ships using various ownership structures. These include outright ownership, leasing, and charter agreements. Over the past three years, the company&#39;s trailing twelve-month revenues have seen very strong growth. Revenue has achieved a compound annual growth rate of 35% over that period.
This has coincided with the company&#39;s share price rising 175% over the last three years. That big rise in share price has also given shareholders big dividends. Over the past twelve months, the company&#39;s dividend yield is 7.9%. Its dividend yield has fluctuated widely over time from 0% to upwards of 20%. However, over the last 10 years, its average is 7.2%.
In addition, analysts see the company maintaining strong revenue and earnings per share growth. Analysts expect those figures to rise at a compound annual rate of 20.8% and 9.7%, respectively. Furthermore, Wall Street analysts see solid upside in the stock despite its strong rise in recent years. The average price target for the company implies a 16% upside from its current level. A recent upgrade by BTIG Research supports this potential upside. The firm moved its rating from Neutral to Buy, placing a $30 target on Frontline.
It is important to note that many of Frontline&#39;s vessels, particularly its largest ones, transport oil from the Middle East to other regions. This adds geopolitical risk to the firm.
<h2>Blackstone: 3% Dividend Yield Combined with A Bottoming Market?</h2>
Next up is Blackstone (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bx#NYSE">BX</a>). The financial services company is the largest alternative asset manager in the world. The company manages various, mostly private, investment funds. They focus on real estate, private equity, infrastructure, and hedge fund strategies. It generates revenue from fees that it charges for managing these funds, as well as from incentive fees generated when the funds perform well. Over the past year, the company has achieved strong share price returns and provided a notable amount of dividend income.
Shares are up 42%, and the company&#39;s trailing twelve-month dividend yield is 2.3%. Analysts project that figure will rise by 3% in the next twelve-month period. On average, analysts expect the company&#39;s revenue and earnings per share to continue growing strongly over the next two years. The expected compound annual growth rates for these metrics are 24% and 22%, respectively.
Some evidence shows that the private investment fund industry may be nearing a bottom. If current trends continue, the amount of capital raised for private equity and venture capital funds in 2024 will be the lowest since 2016. The number of these funds launched in the first half of 2024 is down 47% compared to the first half of 2023. Additionally, falling interest rates have historically led to more deals in this industry. Continued falls in interest rates would increase demand for new Blackstone funds, all else being equal. Additionally, the fact that the industry may be at a fundraising bottom could provide a strong tailwind going forward.
<h2>Seagate: More Data Means More Storage</h2>
Last up is Seagate Technology (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stx#NASDAQ">STX</a>). Seagate makes hardware that stores data on computers. This includes things like hard drives and solid-state drives (SSDs). These devices are where files, videos, and various other types of information are stored on a computer.
Seagate mainly sells its storage solutions to large customers, like data centers. &quot;Mass capacity&quot; customers that require large-scale solutions make up over 90% of the storage Seagate sells. One might consider the company semiconductor-adjacent. Its products rely on semiconductors made by companies like Samsung.
As the world becomes more digitized, there must be more hardware to store digital information. The company cites an International Data Corporation report stating that increased digitization and increased information created by AI will drive demand for data storage. The report expects storage needs to rise by 24% annually through 2028. Analysts are projecting the company&#39;s revenue to rise by 26% annually over the next two years. Additionally, Seagate is expected to provide a respectable dividend yield of 2.6% over the next twelve months.
The article &quot;<a href="https://www.marketbeat.com/stock-ideas/top-income-stocks-offering-big-dividend-yields-and-future-growth/">Top Income Stocks Offering Big Dividend Yields and Future Growth</a>&quot; first appeared on MarketBeat.

Dividends

Top Income Stocks Offering Big Dividend Yields and Future Growth

The Zacks Real Estate Operations industry constituents are poised to gain from the increased adoption of outsourced real estate services and emerging trends. The easing of monetary policy in many large markets is expected to result in a decrease in borrowing costs, more availability of credit and drive economic growth, in turn fueling transaction activity. Companies like Newmark Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nmrk#NASDAQ">NMRK</a>), Kennedy-Wilson Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kw#NYSE">KW</a>) and RE/MAX Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rmax#NYSE">RMAX</a>) are set to benefit from these positive trends.
However, the industry faces challenges such as macroeconomic uncertainty and geopolitical tensions. Customers remain focused on cost controls and for certain asset categories are delaying their decision-making with respect to leasing.
About the Industry
The Zacks Real Estate Operations industry comprises companies that provide leasing, property management, investment management, valuation, development services, facility management, project management, transaction and consulting services, among others. However, real estate investment trusts or REITs are excluded from this group. Economic trends and government policies impact the real estate market (global and regional), which determines the industry&#39;s performance. Economic activity, employment growth, office-based employment, interest-rate levels, costs and availability of credit, tax and regulatory policies, and the geopolitical environment are the major factors shaping the real estate market&#39;s fate. Also, pandemic-induced public health challenges and geopolitical issues have affected property sales and the leasing lines of businesses.
What&#39;s Shaping the Real Estate Operations Industry&#39;s Future?
Interest Rate Cut Provides Relief for Transaction-Based Business: The latest cut in the interest rates by the Federal Reserve and anticipations of future reductions are expected to drive transaction-based businesses in the United States. Along with the United States, the easing of monetary policy in many large markets is expected to result in a decrease in borrowing costs, more availability of credit, and drive economic growth. This is expected to help investors in better price discovery and consequently result in reduced transaction completion times. It is also expected to lead to a rise in the average deal size, thereby bolstering the industry&#39;s near-term revenue prospects.
Outsourcing of Real Estate Needs to Remain Strong: Real estate occupiers, including corporations, public sector entities, healthcare providers, and those in finance, industry, life sciences and technology, are increasingly preferring to outsource their real estate needs. They are entrusting third-party real estate experts to enhance execution and efficiency. Organizations are seeking strategic advice to reimagine their workplaces and workstyles to foster culture, attract talent and improve performance. These developments are creating opportunities for participants in the real estate operations industry. Major players in the industry are leveraging this transition, securing new clients and expanding relationships with existing ones. Also, companies in this industry continue to prioritize investments in technology as it consistently improves efficiency, delivers client services and supports market share growth.
Certain Real Estate Categories&#39; Demand Hurt: The pandemic has significantly reshaped the use of commercial real estate. Also, economic uncertainty continues to affect real estate sales and leasing activities. While companies are promoting the return to office, this transition is gradual, which is hindering tenants&#39; confidence in long-term commitments. As such, pre-pandemic office occupancy levels are likely to remain elusive in the near or intermediate term. Amid a volatile environment and geopolitical issues, customers remain focused on cost controls and delaying their decision-making with respect to leasing. As such, industrial real estate demand remains subdued and this trend is expected to continue in the near term. Additionally, the pace of business-related travel and in-person interactions has not fully rebounded to pre-pandemic norms.
Zacks Industry Rank Indicates Bright Prospects
The Zacks Real Estate Operations industry is housed within the broader Zacks Finance sector. It carries a Zacks Industry Rank #104, which places it in the top 42% of more than 250 Zacks industries.
The group&#39;s Zacks Industry Rank, which is the average of the Zacks Rank of all the member stocks, indicates robust near-term prospects. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than two to one.
The industry&#39;s positioning in the top 50% of the Zacks-ranked industries is a result of the upward earnings per share outlook for the constituent companies in aggregate. Looking at the aggregate earnings per share estimate revisions, it appears that of late, analysts are gaining confidence in this group&#39;s growth potential. Over the past year, the industry&#39;s earnings per share estimates for 2024 and 2025 have moved 46.8% and 37.2% north, respectively.
Before we present a few stocks that you may want to consider for your portfolio, let&#39;s take a look at the industry&#39;s recent stock-market performance and valuation picture.
Industry Outperforms the Sector &amp; the S&amp;P 500
The Zacks Real Estate Operations industry has outperformed the broader Zacks Finance sector and the S&amp;P 500 composite over the past year.
The industry has advanced 40.8% during this period compared with the S&amp;P 500&#39;s growth of 32.5% and the broader Finance sector&#39;s rise of 31.2%.
<h3>One-Year Price Performance</h3>
<img alt="" src="https://staticx-tuner.zacks.com/images/zadmin_tuner_image/priceperf.jpg" style="height:228px; width:620px" />
Industry&#39;s Current Valuation
On the basis of the forward 12-month price-to-earnings, which is a commonly used multiple for valuing Real Estate Operations stocks, we see that the industry is currently trading at 17.06X compared with the S&amp;P 500&#39;s forward 12-month price-to-earnings (P/E) of 22.08X. The industry is trading above the Finance sector&#39;s forward 12-month P/E of 16.66X. This is shown in the chart below.
<h3>Forward 12-Month Price-To-Earnings Ratio</h3>
<img alt="" src="https://staticx-tuner.zacks.com/images/zadmin_tuner_image/ind_&amp;_s&amp;p.jpg" style="height:155px; width:620px" />
<img alt="" src="https://staticx-tuner.zacks.com/images/zadmin_tuner_image/ind_&amp;_fin.jpg" style="height:153px; width:620px" />
Over the last five years, the industry has traded as high as 32.49X and as low as 11.45X, with a median of 17.26X.
3 Real Estate Operation Stocks to Bet On
RE/MAX Holdings: Headquartered in Denver, CO, it is a franchisor in the real estate industry. The company franchises real estate brokerages globally under the RE/MAX brand and mortgage brokerages within the United States under the Motto Mortgage brand. It also sells ancillary products and services, such as loan processing services, mainly to its Motto network.
RE/MAX is poised to benefit from its strategic growth initiatives. With its efforts to expand the mortgage business and its objective to maintain a strong liquidity position, RE/MAX is well-poised to ride the growth curve.
RE/MAX Holdings currently sports a Zacks Rank #1 (Strong Buy). The Zacks Consensus Estimate for the company&#39;s 2024 earnings per share currently stands at $1.24. The stock has increased 20.8% in the past three months.
<img alt="" src="https://staticx-tuner.zacks.com/images/zadmin_tuner_image/rmax.jpg" style="height:214px; width:620px" />
Newmark Group, Inc.: Headquartered in New York City, Newmark is a leading commercial real estate services company that is rapidly expanding its presence globally. Together with its subsidiaries, Newmark Group advises and provides services to large institutional investors, global corporations and other owners and occupiers of commercial real estate.
With investments in talent and technology, the company is expected to experience decent performance going forward. It is poised to benefit from the opportunities from the large and highly fragmented market, institutional investor demand for commercial real estate and from the favorable trend toward outsourcing of commercial real estate services.
Newmark carries a Zacks Rank of 2 (Buy) at present. The Zacks Consensus Estimate for the company&#39;s 2024 EPS has remained unchanged at $1.15 over the past month. This also suggests 9.5% growth year over year. NMRK shares have gained 22.7% over the past three months.
<img alt="" src="https://staticx-tuner.zacks.com/images/zadmin_tuner_image/nmrk.jpg" style="height:215px; width:620px" />
Kennedy Wilson: Headquartered in Beverly Hills, CA, Kennedy Wilson is a global real estate investment company that invests in high-growth markets across the United States, the U.K. and Ireland. KW is engaged in the ownership, operation and investment in real estate on its own and through its investment management platform.
The company is expected to benefit from the continued growth of its investment management business and healthy demand for its high-quality multifamily and commercial portfolio.
Kennedy Wilson has a Zacks Rank of 2 at present. The Zacks Consensus Estimate for 2024 EPS has moved significantly upward over the past two months to $2.96. This suggests a notable increase year over year. The company&#39;s shares have appreciated 32.1% in the past six months.
<img alt="" src="https://staticx-tuner.zacks.com/images/zadmin_tuner_image/kw.jpg" style="height:213px; width:620px" />
<a href="https://www.zacks.com/commentary/2350419/3-stocks-to-buy-on-the-real-estate-operations-industry-s-recovery?cid=CS-BENZ-FT-industry_outlook-2350419">To read this article on Zacks.com click here.</a>

Government

Regulations

Federal Reserve

NMRK

RMAX

3 Stocks to Buy on the Real Estate Operations Industry's Recovery

Seaport Global analyst David Joyce maintains Live Nation Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYV#NYSE">LYV</a>) with a Buy and raises the price target from $115 to $133.

Seaport Global Maintains Buy on Live Nation Entertainment, Raises Price Target to $133

Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) has revealed the Xbox Game Pass Wave 2 lineup for October 2024, and it's headlined by Call of Duty: Black Ops 6, set to release <a href="https://www.benzinga.com/general/gaming">on Oct. 25. </a>
This marks the first time a Call of Duty game has launched day-one on Game Pass, following Microsoft's $69 billion acquisition of Activision Blizzard in 2023. 
This move is part of Microsoft&#8217;s strategy to leverage high-profile titles to expand the Game Pass user base. Phil Spencer, head of Xbox, has long stressed the power of Game Pass in driving engagement and sales.
See Also: <a href="https://www.benzinga.com/general/gaming/24/10/41342256/microsoft-settles-antitrust-lawsuit-filed-by-gamers-over-activision-blizzard-acquisition">Microsoft Settles Antitrust Lawsuit Filed By Gamers Over Activision Blizzard Acquisition</a>
<h3 class="wp-block-heading">A Game Pass Lineup Loaded With Heavy Hitters</h3>
While Black Ops 6 is the crown jewel of this month's additions, the <a href="https://news.xbox.com/en-us/2024/10/15/xbox-game-pass-october-2024-wave-2/?ocid=XGP_soc_omc_xbo_tw_Photo_lrn_10.15.1">October Wave 2 </a>lineup offers much more:
<ul>
<li>South Park: The Fractured but Whole (Cloud, Console, PC) – Oct. 16</li>
<li>Donut County (Cloud, Console, PC) – Oct. 17</li>
<li>MechWarrior 5: Clans (Cloud, PC, Xbox Series X&#x7C;S) – Oct. 17</li>
<li>Call of Duty: Black Ops 6 (Cloud, Console, PC) – Oct. 25</li>
<li>Call of Duty: Modern Warfare 3 (Cloud) – Oct. 25</li>
<li>Call of Duty: Warzone (Cloud) – Oct. 25</li>
<li>Ashen (Cloud, Console, PC) – Oct. 29</li>
<li>Dead Island 2 (PC) – Oct. 31</li>
</ul>
Additionally, looking ahead to November, Microsoft confirmed that StarCraft: Remastered and StarCraft II: Campaign Collection will join Game Pass on Nov. 5.
<h3 class="wp-block-heading">Games Leaving Game Pass On Oct. 31</h3>
As new games arrive, some titles are rotating out of the service. The following will leave Game Pass at the end of October:
<ul>
<li>Frog Detective: The Entire Mystery (Cloud, Console, PC)</li>
<li>Headbangers (Cloud, Console, PC)</li>
<li>Inkulinati (Cloud, Console, PC)</li>
<li>Lonely Mountain's Downhill (Cloud, Console, PC)</li>
<li>Mineko's Night Market (Cloud, Console, PC)</li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/gaming/24/10/41318405/microsoft-to-test-cloud-gaming-for-owned-xbox-games-in-november-report">Microsoft To Test Cloud Gaming For Owned Xbox Games In November: Report</a></li>
</ul>
Image credits: Shutterstock.

Gaming

MSFT

Microsoft's October 2024 Xbox Game Pass Wave 2 Brings Call Of Duty: Black Ops 6 To Subscribers

Last week, Tesla Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsla#NASDAQ">TSLA</a>) unveiled its long-awaited robotaxi, the star of its next chapter. The Cybercab was revealed at the massive Warner Bros Studios in Burbank, California, known as Hollywood. Like the Cybertruck, Tesla&rsquo;s robotaxi has a futuristic design, but the &ldquo;We, Robot&rdquo; event failed to impress. After the event, Tesla CEO Elon Musk&rsquo;s net worth went down by $15 billion as he holds about 13% of the company&rsquo;s shares, but he remains the world&rsquo;s richest person.
<h3>More Information About The Cybercab</h3>
With production scheduled for some time before 2027, Musk also revealed that the Cybercab, which would compete with rivals including Alphabet Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/goog#NASDAQ">GOOG</a>)(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/googl#NASDAQ">GOOGL</a>)-owned Waymo, would cost less than $30,000, which is about the same price as its cheaper Model 3 and Model Y.&nbsp;&nbsp;Moreover, the Cybercab has no plug as it would use inductive charging, one for which Tesla does not currently have infrastructure for, raising many concerns about the cost of making this driverless dream actually happen.&nbsp;
However, Musk remains optimistic despite skepticism.&nbsp;
After a decade of failing to meet his own deadlines, Musk&rsquo;s prediction that production of the Cybercab would begin some time &quot;before 2027&rdquo; is seen as questionable. Paul Miller from Research Forrester believes it will be extremely difficult for Tesla to offer a new vehicle at that price within that timeframe, which means Tesla would be making a loss on every vehicle.
The glitzy showcase failed to shake off the feeling that Tesla is losing the race.
Thursday was supposed to be the unveiling of Tesla&rsquo;s new chapter, providing a glimpse of its future built on Musk&rsquo;s latest driverless dreams. But with Musk&rsquo;s, history of falling short on promises and Tesla&rsquo;s past of safety issues, there are many concerns around the Cybercab. Adding to the fact that Alphabet is already operating with Waymo, along with other Chinese firms, Tesla is still far from disrupting the landscape. Many have faltered with automated driving technology when it came to figuring out a profitable business model. For example, it took Google quite some time to scale Waymo. On Thursday, humanoid Optimus robots served drinks and the world got a glimpse of Tesla&rsquo;s robotaxi fleet, &ldquo;Cybercab&rdquo; and &ldquo;Robovan&rdquo;, with disappointment in the air. While reasons varied, from not-so-thrilling joyrides in the new vehicles to not-so-self-functioning self-functioning robots and so-on, Tesla failed to impress as it goes up against not only Google and its Waymo, but General Motors (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gm#NYSE">GM</a>) and its Cruise autonomous ride-hailing service, as well as Zoox, Amazon.com Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amzn#NASDAQ">AMZN</a>)&rsquo;s self-driving subsidiary. All in all, the market was probably mostly disappointed because they the dazzling event failed not provide any concrete numbers.
DISCLAIMER: This content is for informational purposes only. It is not intended as investing advice.
This article is from an unpaid external contributor. It does not represent Benzinga's reporting and has not been edited for content or accuracy.

AMZN

GOOG

GOOGL

TSLA

Tesla Fails To Justify The Robotaxi Hype With Concrete Figures

Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) showed off its robotaxi autonomous vehicle and a larger autonomous vehicle it referenced as the Robovan during its highly anticipated<a href="https://www.benzinga.com/news/24/10/41284847/tesla-reveals-two-seater-cybercab-that-drives-itself"> Robotaxi Day last week.</a>
Newly uncovered trademark filings could show what names the company prefers for the vehicles and will use going forward.
What Happened: Tesla CEO Elon Musk <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41295072/tesla-robotaxi-day-event-more-fanfare-than-substance-8-analysts-on-cybercab-optimus">showed off the company's vision</a> of an autonomous vehicle that will hopefully take consumers from place to place without needing a driver or any intervention.
The company also showed off a larger vehicle that can take up to 20 passengers to destinations that acts similar to a shuttle.
Both vehicles could be part of the future for Tesla as it looks to autonomous vehicles for growth. Both vehicles also drew pushback from the director of movie "I, Robot" for<a href="https://www.benzinga.com/general/entertainment/24/10/41314770/elon-musk-tesla-accused-of-stealing-ideas-from-i-robot-movie-for-cybercab-robovan-can-i-hav"> their similar designs </a>to vehicles in the movie.
Going forward, one debate for Tesla and Musk could be what to call the vehicles.
Before the Oct. 10 event and during the event, the autonomous vehicle was referenced as both "Cybercab" and "Robotaxi." On Tesla's <a href="https://www.tesla.com/we-robot">website</a>, the company uses the phrase Robotaxi to describe the newly unveiled vehicle.
A report from <a href="https://electrek.co/2024/10/14/tesla-trademarks-robobus-and-robotaxi/">Electrek </a>says Tesla has filed to trademark "Robotaxi" for electric vehicles and for ridesharing and commercial use.
The report also said Tesla has filed to trademark "Robobus," which could indicate the term Robovan used by Musk and the company on Oct. 10 was a placeholder. Tesla's website now uses the term Robovan to describe the vehicle.
You may not be a billionaire like Elon Musk, but you can uncover hidden gems in the stock market using our proprietary data and pattern recognition — <a href="https://www.benzinga.com/general/entertainment/24/10/41187322/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">check out five stocks flying under the radar that deserve your attention.</a>
Why It's Important: Trademark filed don't guarantee that they will be granted or that the company will use the names. In this case, the trademark filings likely point to names that Tesla is considering using for the newly unveiled vehicles.
Tesla's new vehicles are years away from production with Musk sharing a goal of the robotaxi vehicle to be in production before 2027 with a goal of costing under $30,000.
The EV company has been known to overpromise in the past when it comes to production timelines and vehicle costs.
Regardless of what the vehicles are called, autonomous vehicles face <a href="https://www.benzinga.com/general/politics/24/10/41298125/maybe-musk-missed-the-memo-trumps-plan-to-ban-autonomous-vehicles-could-sour-friendship">potential hurdles on regulation </a>on a nationwide basis. Surveys show they must win over consumers who are <a href="https://www.benzinga.com/top-stories/24/10/41279865/elon-musk-may-unveil-teslas-robotaxi-but-consumers-respond-with-ehhh-new-study-reveals-skepticism-ne">scared of the technology.</a>
Price Action: Tesla stock is up 1% to $220.44 on Tuesday versus a 52-week trading range of $138.80 to $271. Tesla stock is down 10% over the last five days and down 11% year-to-date in 2024.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/23/04/32100580/elon-musk-owns-an-iconic-1m-james-bond-movie-car-the-crazy-story-of-couple-who-bought-it-fo">Elon Musk Owns An Iconic $1M James Bond Movie Car: The Crazy Story Of Couple Who Bought It For $100</a></li>
</ul>
Image: Shutterstock

Cybercab Or Robotaxi? Robovan Or Robobus? Tesla Trademark Filings Might Reveal Elon Musk's Preferred Name For New Vehicles

<a href="https://www.bloomberg.com/news/articles/2024-10-15/meta-must-face-some-claims-by-state-ags-in-addiction-lawsuit">https://www.bloomberg.com/news/articles/2024-10-15/meta-must-face-some-claims-by-state-ags-in-addiction-lawsuit</a>
Meta Platforms Inc. must face a lawsuit by dozens of state attorneys general alleging it knowingly contributed to a youth mental health crisis by getting kids hooked on social media.

Legal

'Meta Must Face Some Claims by State AGs in Addiction Lawsuit' - Bloomberg News

Defense and aerospace stocks, as tracked by the iShares US Aerospace &amp; Defense ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ITA#BATS">ITA</a>) have returned a remarkable 22% year-to-date in 2024; an aerospace expert weighed in on whether companies can keep up with sky-high valuations <a href="https://www.benzinga.com/markets/commodities/24/10/41150239/investors-look-to-gold-as-middle-east-tensions-rise-how-israel-iran-conflict-could-impact-pri">fueled by tensions</a> in the Middle East.
The Aerospace Analyst: RBC analyst Ken Herbert reiterated Outperform ratings for the following aerospace companies in a note published Monday:
<ul>
<li>Boeing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>), lowering its price target from $220 to $200.</li>
<li>General Electric Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>), raising its price target from $190 to $210.</li>
<li>General Dynamics Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GD#NYSE">GD</a>), maintaining its price target at $320.</li>
<li>Airbus SE (OTC:<a class="ticker" href="https://www.benzinga.com/stock/EADSY#OTC">EADSY</a>), lowering its price target from 180 euros to 160 euros.</li>
</ul>
Industry Takeaways: Herbert noted the industry&#8217;s impressive performance in 2024.
&#8220;Investor sentiment into 3Q24 A&amp;D results is positive on defense stocks, with concerns about near-term incremental upside after the recent strength for many defense stocks. Sentiment seems universally bullish on the aerospace aftermarket, although these stocks appear about as crowded on the long side as we have seen,&#8221; the analyst said. &#8220;We believe the aero OE outlook is uncertain at best.&#8221;
The analyst noted his belief that aerospace valuations will hold in the near-to-mid term.
Boeing Takeaways: Herbert says that Boeing&#8217;s current risk-to-reward is favorable.
&#8220;We believe we are ~36 months into what should be a 4-to 5-year order cycle. Granted, the world is different today than it was for any prior cycle, but we expect demand for narrowbody aircraft to remain strong,&#8221; Herbert said.
The analyst believes that the ongoing labor strike at Boeing will be resolved before it releases its third-quarter earnings.
GE Aero Takeaways: Although Herbert raised General Electric&#8217;s price target, he simultaneously lowered expectations of 2024, 2025 and 2026 LEAP engine deliveries.
&#8220;While we are more cautious on revenue growth, we are raising our estimates for adj operating income and adj. EPS as GE Aero benefits from mix,&#8221; the analyst said. &#8220;We believe the healthy aftermarket demand fundamentals and continued favorable pricing on spare parts will offset downside risk to new LEAP deliveries, although investors will likely be focused on execution for this program.&#8221;
Herbert believes that the bear case for GE is &#8220;fading&#8221; amid efforts to derisk its balance sheet.
General Dynamics Takeaways: Herbert&#8217;s lowering of General Dynamics&#8217; price target comes amid pessimism in Gulfstream delivery estimates. The analyst sees headwinds ahead in delivering its G700 aircraft.
Herbert is still bullish on the company, with a perceived upside amid the continuing war in Ukraine.
Airbus Takeaways: The analyst&#8217;s lowered price target is attributed to lower delivery estimates in the near term. He believes the stock can perform well, even though the company will likely walk back its mid-decade target of 1,000 deliveries.
Herbert sees Airbus&#8217; core strengths as its strong backlog, cash position and margin expansion.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/markets/asia/24/10/41336413/oil-prices-take-largest-plunge-in-over-a-year-as-israel-vows-to-spare-iranian-facilities-energy-stoc">Oil Prices Take Largest Plunge In Over A Year As Israel Vows To Spare Iranian Facilities: Energy Stocks Sink, Airlines, Cruise Lines Rally</a></li>
</ul>
Photo: Gorodenkoff/Shutterstock.com

Equities

Reiteration

European Aeronautic Defence And Space Unsponsored

EADSY

iShares Dow Jones US Aerospace & Defense Index Fund

Aerospace Stocks Face Tough Questions: Can Boeing, GE, Airbus Justify Sky-High Valuations?

WIIM

Trump Media & Technology Group shares are trading lower amid volatility after Donald Trump concluded his Bloomberg interview and a Reuters/ipsos poll indicated that Vice President Harris is leading ahead of the U.S. presidential election.

Citigroup analyst Jason Gursky maintains Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) with a Buy and lowers the price target from $224 to $209.

Citigroup Maintains Buy on Boeing, Lowers Price Target to $209

Over the past 24 hours, Immutable's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">IMX</a>) price has fallen 3.72% to $1.59. This is opposite to its positive trend over the past week where it has experienced a 10.0% gain, moving from $1.44 to its current price. 
The chart below compares the price movement and volatility for Immutable over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.
<img src="https://www.benzinga.com/files/images/story/2024/1729019022_0.png" alt="price_chart" />
The trading volume for the coin has increased 28.0% over the past week while the overall circulating supply of the coin has increased 1.91% to over 1.64 billion which makes up an estimated 81.89% of its max supply, which is 2.00 billion. The current market cap ranking for IMX is #41 at $2.60 billion.
<img src="https://www.benzinga.com/files/images/story/2024/1729019022_1.png" alt="supply_and_vol" />
<a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

$IMX

Cryptocurrency Immutable Decreases More Than 3% Within 24 hours

Over the past 24 hours, Fantom's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ftm/usd">FTM</a>) price rose 8.14% to $0.79. This continues its positive trend over the past week where it has experienced a 16.0% gain, moving from $0.66 to its current price. As it stands right now, the coin's all-time high is $3.46. 
The chart below compares the price movement and volatility for Fantom over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.
<img src="https://www.benzinga.com/files/images/story/2024/1729018953_0.png" alt="price_chart" />
Fantom's trading volume has climbed 32.0% over the past week along with the circulating supply of the coin, which has increased 0.11%. This brings the circulating supply to 2.80 billion, which makes up an estimated 88.3% of its max supply of 3.17 billion. According to our data, the current market cap ranking for FTM is #47 at $2.20 billion.
<img src="https://www.benzinga.com/files/images/story/2024/1729018953_1.png" alt="supply_and_vol" />
<a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$FTM

Cryptocurrency Fantom Rises More Than 8% In 24 hours

Artificial Superintelligence Alliance's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/fet/usd">FET</a>) price has decreased 3.26% over the past 24 hours to $1.47. This is contrary to the coins performance over the past week where it has experienced an up-trend of 4.0%, moving from $1.41 to its current price.
The chart below compares the price movement and volatility for Artificial Superintelligence Alliance over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.
<img src="https://www.benzinga.com/files/images/story/2024/1729018944_0.png" alt="price_chart" />
The trading volume for the coin has climbed 58.0% over the past week, moving opposite, directionally, with the overall circulating supply of the coin, which has decreased 0.35%. This brings the circulating supply to 2.61 billion, which makes up an estimated 95.97% of its max supply of 2.72 billion. According to our data, the current market cap ranking for FET is #31 at $3.83 billion.
<img src="https://www.benzinga.com/files/images/story/2024/1729018944_1.png" alt="supply_and_vol" />
<a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$FET

Cryptocurrency Artificial Superintelligence Alliance Falls More Than 3% In 24 hours

StoneCo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STNE#NASDAQ">STNE</a>) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for StoneCo, revealing an average target of $13.0, a high estimate of $18.00, and a low estimate of $7.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 18.14%. 
<img src="https://www.benzinga.com/files/images/story/2024/1729018913_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
A clear picture of StoneCo's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>John Coffey</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$13.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Jorge Kuri</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$7.00</td>
<td>$16.50</td>
</tr>
<tr>
<td>Kaio Prato</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$18.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>John Coffey</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$14.00</td>
<td>$16.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to StoneCo. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of StoneCo compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for StoneCo's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into StoneCo's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/STNE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on StoneCo analyst ratings.</a>
<h2>Unveiling the Story Behind StoneCo</h2>
StoneCo Ltd is a provider of financial technology solutions. It serves MSMBs great solutions, at fair prices, and provides the customer experience to help them manage their businesses and sell more. Its Stone Business Model combines end-to-end, cloud-based technology platforms; differentiated hyper-local and integrated distribution approaches; and white-glove, on-demand customer service. It has two segments Financial Services offers payments, digital banking, and credit solutions, focusing Ton solution mainly on micro-merchants, and Stone solution on SMBs. In Software, it offers POS and ERP solutions for different retail and services verticals, Customer Relationship Management, engagement tools, e-commerce, and Order Management System solutions, among others.
<h3>StoneCo: A Financial Overview</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: StoneCo displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 11.86%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.
Net Margin: StoneCo's net margin excels beyond industry benchmarks, reaching 16.07%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): StoneCo's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 3.29%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): StoneCo's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.95%, the company may face hurdles in achieving optimal financial performance.
Debt Management: StoneCo's debt-to-equity ratio is below the industry average. With a ratio of 0.61, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>What Are Analyst Ratings?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

STNE

Critical Insights From StoneCo Analyst Ratings: What You Need To Know

Citigroup analyst Jon Tower maintains Denny's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DENN#NASDAQ">DENN</a>) with a Neutral and lowers the price target from $8 to $7.

DENN

Citigroup Maintains Neutral on Denny's, Lowers Price Target to $7

Chemomab Therapeutics regains compliance with Nasdaq

Maxim Group analyst Michael Okunewitch has maintained their bullish stance on CMMB stock, giving a Buy rating yesterday. Michael Okunewitch's ratin...

Promising Phase 2 Results and Strong Financials Underpin Buy Rating for Chemomab Therapeutics

Chemomab Therapeutics GAAP EPS of -$0.01

Chemomab Therapeutics (CMMB) has released an update. Chemomab Therapeutics Ltd. has released its unaudited interim condensed consolidated financial...

Chemomab Therapeutics Reports Mid-Year Financials

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Chemomab Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cmmb-stock-quote/">CMMB</a>) just reported results for the second quarter of 2024.<ul><li>Chemomab Therapeutics reported earnings per share of -26 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/cmmb-stock-earnings-chemomab-therapeutics-for-q2-of-2024/">CMMB Stock Earnings: Chemomab Therapeutics Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

CMMB Stock Earnings: Chemomab Therapeutics Reported Results for Q2 2024

Oppenheimer analyst Jeff Jones maintained a Buy rating on Chemomab Therapeutics (CMMB – Research Report) today and set a price target of $13.00. Th...

Chemomab Therapeutics (CMMB) Gets a Buy from Oppenheimer

Maxim Group analyst Michael Okunewitch has maintained their bullish stance on CMMB stock, giving a Buy rating today. Michael Okunewitch has given h...

Chemomab Therapeutics: Strong Buy Rating on Robust Financials and Positive Clinical Trial Outcomes

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Chemomab Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cmmb-stock-quote/">CMMB</a>) just reported results for the second quarter of 2024.<ul><li>Chemomab Therapeutics reported earnings per share of -26 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div>	The post <a href="https://investorplace.com/earning-results/2024/08/cmmb-stock-earnings-chemomab-therapeutics-for-q2-of-2024/">CMMB Stock Earnings: Chemomab Therapeutics Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Chemomab Therapeutics (CMMB) has released an update. Chemomab Therapeutics Ltd. invites shareholders to a Special General Meeting on November 18, 2...

Chemomab Therapeutics Announces Shareholder Meeting

CMMB

Health Care

Press Releases

Chemomab Therapeutics Announces New Publications Reinforcing the Clinical Potential of Its CCL24-Neutralizing Antibody CM-101 in Primary Sclerosing Cholangitis

Chemomab Therapeutics Announces Positive Phase 2 Trial Results: CM-101 Achieves Primary and Secondary Endpoints Demonstrating Anti-Fibrotic, Anti-Inflammatory and Anti-Cholestatic Effects in Patients with Primary Sclerosing Cholangitis

Financing

Chemomab Therapeutics Announces $10 Million Private Placement

Chemomab Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement

Chemomab Therapeutics Announces Closing of $10 Million Private Placement

Chemomab Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Business Update

Chemomab Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update

Chemomab Therapeutics to Present at September 2024 Investor Conferences

Chemomab Therapeutics to Present at October 2024 Investor Conferences

Chemomab Therapeutics Announces Late-Breaking Oral Presentation of CM-101 Phase 2 Results in Primary Sclerosing Cholangitis at AASLD The Liver Meeting® 2024

Comments

Chemomab Therapeutics

Interés en corto

Chemomab Therapeutics (NASDAQ:CMMB) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL